Kennedy Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.78M | Buy |
427,036
+17,544
| +4% | +$319K | 0.19% | 204 |
|
|
2025
Q1 | $8.12M | Buy |
409,492
+139,840
| +52% | +$2.77M | 0.19% | 181 |
|
|
2024
Q4 | $4.62M | Sell |
269,652
-117,157
| -30% | -$2.01M | 0.1% | 342 |
|
|
2024
Q3 | $7.73M | Sell |
386,809
-44,324
| -10% | -$886K | 0.17% | 211 |
|
|
2024
Q2 | $4.82M | Buy |
431,133
+185,369
| +75% | +$2.07M | 0.1% | 333 |
|
|
2024
Q1 | $1.62M | Sell |
245,764
-288,411
| -54% | -$1.9M | 0.03% | 555 |
|
|
2023
Q4 | $2.41M | Sell |
534,175
-256,872
| -32% | -$1.16M | 0.05% | 453 |
|
|
2023
Q3 | $2.83M | Sell |
791,047
-318,038
| -29% | -$1.14M | 0.07% | 400 |
|
|
2023
Q2 | $4.09M | Buy |
1,109,085
+400,507
| +57% | +$1.48M | 0.1% | 333 |
|
|
2023
Q1 | $2.35M | Sell |
708,578
-1,540,893
| -69% | -$5.1M | 0.07% | 383 |
|
|
2022
Q4 | $8.73M | Buy |
+2,249,471
| New | +$8.73M | 0.25% | 134 |
|